Mergers and acquisitions play a crucial role in the business world. Companies that combine forces can expand their overall book of business, execute in new markets, or serve new customer groups where they previously had no presence. The importance of M&A is even more pronounced in today's digital age. Popular websites, apps, or platforms can now serve hundreds of millions or even billions of users. Innovative technologies or new products can be infinitely scalable and quickly applied across an entire business. Sometimes, even very small teams who possess extremely promising IP or serve a strong product-market fit can be acquired by the right company for a huge premium. Those premiums paid for acquisitions can also be extremely rewarding for investors. When a publicly-traded company gets acquired, its stock price can increase by 50%, 100%, or more in a single day on the news of the acquisition. And the companies who build their businesses around M&A activity -- such as Salesforce (NYSE: CRM), Middleby (Nasdaq: MIDD), or Berkshire Hathaway (NYSE: BRK-B) -- can methodically unlock hidden value that compounds their own investment returns for decades. So where are the most lucrative potential acquisition targets today? Are there sectors of the market that are particularly appealing? Are there clever leadership teams leveraging new technologies that could fit perfectly in a more established company? Are there specific signs that investors should look for, which might suggest to us that a company is gearing up to make an acquisition...or to have itself be acquired? In our July Team Podcast, our 7investing advisors share seven companies we believe could be prime acquisition targets right now. We describe what makes these companies particularly appealing and who their most likely suitors could be. We even taking things one step further, and predict which of our previous 7investing recommendations these acquisitions would have the greatest impact on. If you'd like to see that report, as well as get immediate access to all 119 of our previous recommendations, use this link to sign up for 7investing today. We'll also be providing a short text description below of each potential acquisition target we mentioned in the podcast. We'll update these recaps daily (adding one new writeup each day), so come back often to see our most updated descriptions! Potential Acquisition #1: Alteryx (Nasdaq:AYX) -- Anirban Mahanti believes Alteryx's (Nasdaq: AYX) expertise in transforming raw data sets into insightful analytics positions it as an excellent acquisition target. Its stock price has languished on slowing growth, though Anirban believes this was largely due to the COVID pandemic and also a change in the company's revenue recognition policy. Alteryx was a leader in on-premise deployments, making it attractive for any company looking to expand its expertise to the cloud. He believes Salesforce, IBM, or Oracle could be the most likely suitors. Click here to read Anirban's Potential Acquisitions perspective! Publicly-traded companies mentioned in this interview include Alteryx, IBM, and Salesforce. 7investing's advisors may have positions in the companies mentioned.

Going public with less scrutiny can be a wonderful thing for some companies but scrutiny tnd to benefit investors. The SEC may be difficult to deal with, but the long road to a traditional IPO contains a lot of checks and balances that tend to make those deals more transparent. Simon Erickson joins Dan Kline on 7investing Now to discuss where SPACs stand, why the number of companies going public this way has slowed, and when/if investors should buy shares in companies that go public this way. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

Dr. Sandy Magnus has quite literally seen the world from a much higher point of view. As a former NASA astronaut, one who even lived four months on the International Space Station, she’s had a direct look for decades at the world’s most innovative technologies. She’s also a hero and an incredible role model to millions of people across our planet. But outer space is also capturing the imagination of the business world as well. Billionaire entrepreneurs are committing fortunes to launch companies that build reusable rockets, offer satellite-based internet, or even launch tourists into orbit. There are huge opportunities now developing for the private sector. In this exclusive interview with 7investing, Sandy shares her thoughts about the new “space economy”. She also discusses what technologies will be most-needed for off-world colonization and describes several things that people interested in this space should have on their radar. This interview was recorded in March 2020, and republished on July 20, 2021. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

Hitting a $100 billion valuation marks a major milestone for a drug company, but it has also been a mark that tends to be hard to grow beyond. For many drug makers, it has been sort of a hard wall, but there are reasons that may or may not be true for Moderna, according to Maxx Chatsko. In addition, Zoom spent $14.7 billion to buy Five9, an intelligent cloud contact center company. Steve Symington joins Maxx and Dan Kline to break down what the deal means. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

Most of the 7investing team joins the show to share their process for adding stocks to their personal holdings. We’ll talk about what it takes to get on our radar and when we actually make the decision to buy (as well as how we buy). We’ll also be talking investing mistakes we wish we could have back and be taking your questions live at a special 12:30 p.m. start time. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

Special purpose acquisition companies -- commonly known as "SPACs" -- are becoming increasingly popular in recent years as a way for companies to reach the public markets. While there were only 59 companies that chose to do a "SPAC IPO" in 2019, more than 360 have already taken place thus far in 2021. The total value of funds raised from those SPAC IPOs this year has exceeded $112 billion, and there are reportedly more than 300 more SPACs that have raised funds and are looking for a target. But what will the modern SPAC Race mean for investors? Is this indeed a more capital-efficient way for companies to raise money and go public? Or are investors throwing money at an unproven and potentially dangerous new trend? To answer those questions, 7investing Lead Advisors Simon Erickson and Steve Symington are digging deeper into the recent SPAC craze. In part two of their two-part podcast series, Simon and Steve dig deeper in the way that SPACs are structured and present the important factors that investors should consider. They also take a look at four SPACs that have gained a lot of attention this year -- SoFi, Ginkgo Bioworks, OpenDoor, and Rocket Lab -- and evaluate each of them as potential investment ideas. Publicly-traded companies mentioned in this podcast include Bayer, OpenDoor, SoFi, Vector Acquisition Corp, and Virgin Galactic. 7investing Lead Advisors may have positions in the companies that are mentioned. This interview was originally recorded on July 14th, 2021. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

The pandemic has led to a shortage of workers as some people have opted to not come back to the workforce for reasons ranging from childcare issues (and schools not being fully open) to others opting to keep collecting unemployment. That has forced many large companies offer wages that reach or even exceed $15 an hour. It could also make those same businesses consider they want to spend the money needed to automate their workforce. Anirban Mahanti joins Dan Kline to break down the labor market and what automation might look like.

 The restaurant industry suffered as much as any other during the pandemic. Dining rooms closed, companies had to pivot to takeout and curbside pickup. Even when dining rooms could open, they opened with limited capacities in many places. Despite that, consumers were actually fairly happy with the industry, according to results from the most recent American Customer Satisfaction Index (ACSI). David VanAmburg, Managing Director of the ACSI joined the 7investing Podcast to explain why consumers were forgiving of the restaurant industry at large despite the challenging operating environment. VanAmburg joined Dan Kline to break down why the winners in the space succeeded and why a really large brand continues to bring up the rear of the annual survey when it comes to the fast-food part of the survey. It was a very strange year, but survey scores did not move very much and very few brands saw their scores move up or down more than 1%. VanAmburg also shared his outlook for the next year and what we should be watching for.    Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year.  Start your journey toward's financial independence: https://www.7investing.com/subscribe  Stop by our website to level-up your investing education: https://www.7investing.com  Follow us on Social Media  ► https://www.facebook.com/7investing/  ► https://twitter.com/7investing  ► https://instagram.com/7investing

“Black Widow” had a great weekend at the box office, but that’s not the full story. Walt Disney also took in big bucks through people paying a premium to watch the movie through the Disney+ streaming service. Is that the new normal or an anomaly? We’ll also discuss Virgin Galactic’s successful space flight and whether the FDA will admit it made a mistake in approving a controversial Alzheimer's drug.

The facilitator of online retail has made a deal with the internet retail giant to make faster back-end services available to its customers. This is clearly an attempt by BigC to offer services that rival those offered by Shopify. The question remains -- and it’s a really big question -- is will BigCommerce’s customers want Amazon to have access to their data? The answer has been a resounding “no” in other cases where Amazon tried to offer direct merchant services, but it could be different this time. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investingofficial

Special purpose acquisition companies -- commonly known as "SPACs" -- are becoming increasingly popular in recent years as a way for companies to reach the public markets. While there were only 59 companies that chose to do a "SPAC IPO" in 2019, more than 360 have already taken place thus far in 2021. The total value of funds raised from those SPAC IPOs this year has exceeded $112 billion, and there are reportedly more than 300 more SPACs that have raised funds and are looking for a target. But what will the modern SPAC Race mean for investors? Is this indeed a more capital-efficient way for companies to raise money and go public? Or are investors throwing money at an unproven and potentially dangerous new trend? To answer those questions, 7investing Lead Advisors Simon Erickson and Steve Symington are digging deeper into the recent SPAC craze. In part one of their two-part podcast series, Simon and Steve give an overview of how SPACs are structured and why financial sponsors are incredibly important to their success. The two also discuss specific metrics that investors should be watching and specific risks they should consider. Publicly-traded companies mentioned in this podcast include Virgin Galactic and SoFi. 7investing Lead Advisors may have positions in the companies that are mentioned. This interview was originally recorded on July 8th, 2021 and was first published on the same day. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investingofficial

The Chinese government has shut down new registrations for Didi, a ride-sharing app that just had an IPO on the New York Stock Exchange. This was the biggest IPO since Alibaba in 2014 and the government’s move has investors questioning whether more regulation will be coming for other publicly-traded stocks that are based in China. Maxx Chatsko and Steve Symington join Dan Kline on the July 7 edition of “7investing Now” to figure out what this means for the long-term prospects of investing in China. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investingofficial

It's often said that biotech stocks trade on binary events, such as public disclosures of clinical trial data or regulatory approvals. That's true to some extent, but there's a bit more nuance for investors to consider. Pre-commercial drug developers don't have recurring revenue, earnings, or operating cash flow to interrogate when determining fair value, which forces Wall Street analysts and savvy investors to lean on other valuation tools. Net present value (NPV) and risk-adjusted net present value (rNPV) models can be built to account for the lack of traditional financial fundamentals and the high-risk nature of drug development. Although imperfect, these tools provide a rough, quantitative tool to properly value drug assets. For example, rNPV models can estimate the probability of success (POS) that a drug candidate in a phase 1 clinical trial will reach the market. That percentage can then be slapped onto future expected cash flows and adjusted for the time value of money to determine what the asset might be worth right now. Of course, no one knows the true POS of any single drug candidate. Wall Street analysts often plug in historical averages for specific therapeutic modalities (ex: monoclonal antibodies or kinase inhibitors) in specific therapeutic areas (ex: oncology or neurology). This modeling imperfection and crude estimation is what causes the perception of binary events. When a biotech stock craters or soars on a clinical data readout, it's often because Wall Street models are being updated all at once. Similarly, when a large drug developer pays a hefty premium to acquire a smaller peer, it's often because they're applying a much higher POS to the pipeline being acquired -- likely due to a deeper technical understanding of the science involved. In other words, there's a tremendous amount of value residing in POS differentials. If investors can build relatively accurate rNPV models that incorporate a technical understanding of the underlying drug candidates, then they should be able to stay one step ahead of Wall Street by discovering undervalued companies sooner and avoiding overvalued drug developers altogether. 7investing Lead Advisor Maxx Chatsko is learning how to build rNPV models and incorporate them into his research frameworks. In this episode of the podcast, 7investing CEO and Lead Advisor Simon Erickson chats with him about how to value biotech stocks, a high level explanation of what metrics go into these models, and how they could potentially be applied to new investing areas such as synthetic biology and industrial biotechnology. Publicly-traded companies mentioned in this podcast include Intellia Therapeutics and Johnson & Johnson. 7investing Lead Advisors may have positions in the companies that are mentioned. This interview was originally recorded on July 6th, 2021 and was first published on the same day.

It’s 4th of July weekend and we’re celebrating with a special edition of “7investing Now.” On this episode Anirban Mahanti joins Dan Kline to break down how anyone can take control of their finances and begin their investing journey. They’ll discuss what you have to do before you can start investing and then they’ll layout the steps you need to take to build long-term wealth. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

Note: This is Part 2 of our two-part 7investing interview with Muji. If there's one thing you can count on with technology, it's that it can completely change the way we do things.   Music that used to be played on vinyl records is now being listened to through Bluetooth earbuds as digital mp3. Film reels in movie theaters were replaced by VCRs, which then got replaced by Smart TV streaming. Stick-shift cars eventually became fully-autonomous, while libraries evolved into digital assistants in our living room. There's no industry that's immune to technological innovation. Even our coffee is now being made and served by robot baristas!   This pace of innovation continues to accelerate further, as advancements in cloud computing and artificial intelligence are unlocking new opportunities for organizations of all sizes. Forward-thinking businesses are increasing sales by learning more about their customers, while those with complex supply chains are becoming more efficient by taking costs out of their operations. All of this innovation is excellent news for growth-style investors. By understanding the fundamental technologies that are shaping the future, we can identify the most promising companies who are capitalizing upon them.   So what are those important trends that are brewing today? And what are the specific investment opportunities that are arising?   To answer those questions, we've brought in a technical expert. Matthew Eash -- better known by his online moniker "Muji" -- is one of the world's most forward-thinking technologists. After spending decades as a data architect, he's now founded his hhhypergrowth newsletter to focus on the technologies powering today's most innovative companies. In this exclusive conversation, Muji speaks with 7investing CEO Simon Erickson about the important trends taking shape in the tech world. Muji discusses why the recent Confluent (Nasdaq: CFLT) IPO is so interesting to him and why several companies built upon open-source platforms often end up butting heads with the Cloud Titans. The two discuss usage-based pricing and the metrics investors should be evaluating in the new era of cloud-native software companies. They describe why Snowflake (Nasdaq: SNOW) is such a unique opportunity, as well as a variety of other topics that range from Kubernetes to edge networks.   Finally, Muji takes a closer look at several important events that have taken place in the cybersecurity industry during the past year, including the SolarWinds data breach and FireEye (Nasdaq: FEYE) spinning off its products division. He also describes what impact the White House's recent Executive Order will have on Zero Trust technology.   Muji and Simon share several of their favorite investment ideas throughout the conversation. This is a must-listen for any investors who want to capitalize on the biggest trends taking shape in technology! Publicly-traded companies mentioned in this interview include Alphabet (Nasdaq: GOOGL), Amazon (Nasdaq: AMZN), Cloudera (NYSE: CLDR), Confluent (Nasdaq: CFLT), CrowdStrike (Nasdaq: CRWD), Elastic (NYSE: ESTC), Fastly (Nasdaq: FSLY), FireEye (Nasdaq: FEYE), Fortinet (Nasdaq: FTNT), Microsoft (Nasdaq: MSFT), MongoDB (Nasdaq: MDB), Okta (Nasdaq: OKTA), Palo Alto Networks (NYSE: PANW), Snowflake (Nasdaq: SNOW), Splunk (Nasdaq: SPLK), Twilio (NYSE: TWLO), and ZScaler (Nasdaq: ZS). 7investing's advisors or its guests may have positions in the companies mentioned.

We’re headed into 4th of July weekend and we’re doing the first of two special shows focusing on achieving financial freedom. But, breaking news has caused us to change plans a little bit and we’re going to kick off the show by Walmart’s blockbuster plan to sell insulin for about half what it currently goes for. Dana Abramovirtz and Maxx Chatsko join “7investing Now” to discuss whether this could be a major market disruptor and force drug companies to make changes,. Then, we’re going to talk about Dana’s journey as a business owner and how you can take charge of your financial future. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

 If there's one thing you can count on with technology, it's that it can completely change the way we do things. Music that used to be played on vinyl records is now being listened to through Bluetooth earbuds as digital mp3. Film reels in movie theaters were replaced by VCRs, which then got replaced by Smart TV streaming. Stick-shift cars eventually became fully-autonomous, while libraries evolved into digital assistants in our living room. There's no industry that's immune to technological innovation. Even our coffee is now being made and served by robot baristas! This pace of innovation continues to accelerate further, as advancements in cloud computing and artificial intelligence are unlocking new opportunities for organizations of all sizes. Forward-thinking businesses are increasing sales by learning more about their customers, while those with complex supply chains are becoming more efficient by taking costs out of their operations. All of this innovation is excellent news for growth-style investors. By understanding the fundamental technologies that are shaping the future, we can identify the most promising companies who are capitalizing upon them. So what are those important trends that are brewing today? And what are the specific investment opportunities that are arising? To answer those questions, we've brought in a technical expert. Matthew Eash -- better known by his online moniker "Muji" -- is one of the world's most forward-thinking technologists. After spending decades as a data architect, he's now founded his hhhypergrowth newsletter to focus on the technologies powering today's most innovative companies. In this exclusive conversation, Muji speaks with 7investing CEO Simon Erickson about the important trends taking shape in the tech world. Muji discusses why the recent Confluent (Nasdaq: CFLT) IPO is so interesting to him and why several companies built upon open-source platforms often end up butting heads with the Cloud Titans. The two discuss usage-based pricing and the metrics investors should be evaluating in the new era of cloud-native software companies. They describe why Snowflake (Nasdaq: SNOW) is such a unique opportunity, as well as a variety of other topics that range from Kubernetes to edge networks. Finally, Muji takes a closer look at several important events that have taken place in the cybersecurity industry during the past year, including the SolarWinds data breach and FireEye (Nasdaq: FEYE) spinning off its products division. He also describes what impact the White House's recent Executive Order will have on Zero Trust technology. Muji and Simon share several of their favorite investment ideas throughout the conversation. This is a must-listen for any investors who want to capitalize on the biggest trends taking shape in technology! Publicly-traded companies mentioned in this interview include Alphabet (Nasdaq: GOOGL), Amazon (Nasdaq: AMZN), Cloudera (NYSE: CLDR), Confluent (Nasdaq: CFLT), CrowdStrike (Nasdaq: CRWD), Elastic (NYSE: ESTC), Fastly (Nasdaq: FSLY), FireEye (Nasdaq: FEYE), Fortinet (Nasdaq: FTNT), Microsoft (Nasdaq: MSFT), MongoDB (Nasdaq: MDB), Okta (Nasdaq: OKTA), Palo Alto Networks (NYSE: PANW), Snowflake (Nasdaq: SNOW), Splunk (Nasdaq: SPLK), Twilio (NYSE: TWLO), and ZScaler (Nasdaq: ZS). 7investing's advisors or its guests may have positions in the companies mentioned.

We’re back baby! But normal might not look the same going forward. It’s possible that the pandemic has changed certain behaviours. That will be good for some industries, bad for others, and just generally change the rules for many more. Maxx Chatsko joins Dan Kline to break down how this might work for investors. We’ll also check in on Intellia Therapeutics and take your questions. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

A lot of money has been made by tracking our identities on the internet. Social media sites follow our behavior and use those breadcrumbs to serve us ads even though we never opted in to letting that happen. That’s in the process off changing as we move to an opt-in world where companies have to explicitly ask for permission and Simon Erickson joins 7investing Now to explain what this means for investors. Plus, Anirban Mahanti sat down with Dan Kline to discuss whether there’s a real chance Comcast buys Roku or makes a deal with ViacomCBS. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

Improving health care by making it more convenient The journey a patient makes in the health care system can be a long one - from getting an appointment, to waiting to see the physician, to finally getting a prescription for treatment.  Any roadblock on that journey, often something simple such as picking up a prescription, can have devastating consequences. Value-based care is all about focusing on the patient - providing them the best quality care for the least amount of cost. It is also about treating the patient more as a consumer and giving them the delightful experience that they get from their other service and retail providers.  Oftentimes, what the patient consumer is looking for is convenience. Convenient is certainly not a word one typically associates with health care.  But that’s changing.  Telehealth has finally gained acceptance, a silver lining from the pandemic, wearables are connecting to doctors’ offices, and increasingly medical networks have a usable patient app.  It may not be perfect yet, but it’s heading in the right direction. In today’s podcast, 7investing Lead Advisor Dana Abramovitz discusses how companies are making health care more convenient to patients with Amanda Epp, Co-founder and CEO of ScriptDrop.  ScriptDrop focuses on the last leg of the patient journey, getting their prescription. Publicly-traded companies mentioned in this podcast include: Rite Aid (NYSE: RAD), Albertson’s (NYSE: ACI), CVS (NSYE: CVS), Walgreens (NASDAQ: WBA), and Amazon (NASDAQ: AMZN). 7investing’s advisors may have positions in the companies mentioned. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

You can’t invest if you don’t have excess money in your budget. A lot of people make little financial mistakes that collectively hurt their ability to buy stocks and make long-term financial moves. Maxx Chatsko joins Dan Kline to talk about some of the financial drains that can be avoided (and a few that maybe can’t). We’ll also look at the first in vivo clinical results for CRISPR gene editing. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

"10-Baggers" are prime examples of the amazing power of compounding in investing. The term was originally coined by legendary investor Peter Lynch in his book <em>One Up on Wall Street.</em> It refers to a company that goes on to return 10 times your initial investment, turning $1,000 into $10,000 or $100,000 into $1 million. Lynch went on to become one of the greatest money managers of all time. He ran Fidelity's Magellan Fund for 13 years and achieved an incredible compound average growth rate of 29.2%. During his time at the helm, Lynch <a href="https://www.forbes.com/2009/02/23/lynch-fidelity-magellan-personal-finance_peter_lynch.html?sh=407e3fb4474d">stocked the Magellan Fund</a> with more than 100 companies that went on to become 10-Baggers. Stocks that generate those types of returns can completely change your entire financial future. Buying into just a few 10-Baggers can supercharge the overall returns of even a diversified investment portfolio. But finding these high-flying performers is no easy feat. It requires diligent upfront research, a methodical investing process, and a boatload of patience. Are there future 10-Baggers available in the stock market today? If so, how do we go about finding them? And if we're fortunate enough to find and invest in them, how should we deal with them becoming an outsized position? In our June Team Podcast, our 7investing advisors share our approach to finding 10-Baggers. We reveal the different metrics and factors that we each look for, as well as several of the personal lessons we've learned along the way. Publicly-traded companies mentioned in this interview include Alnylam Pharmaceuticals, Apple, Costco, CrowdStrike, FireEye, MongoDB, Repligen, Tesla, and Ubiquiti Inc. 7investing's advisors may have positions in the companies mentioned.

The pandemic changed a lot about how many white-collar workers work. Many people who used to go to an office every day stopped doing that. Going forward, not everyone will be heading back to a traditional five-day-a-week in-office work schedule. That’s going to have ramifications across the economy. Steve Symington joins Dan Kline on “7investing Now” live at noon to discuss what this means for investors. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

We’re checking in on the progress of the space race and looking at Google’s partnership with a hospital chain to disrupt healthcare. In addition, we’ll take a look at just how far momentum can take drug companies and examine some of the legislative attempts to regulate big tech. Then, we’ll close the show by talking about the investing advice we wish we had known sooner. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

America's health care system is a complex beast. It's costing us $4 trillion per year -- roughly $11,000 for every man, woman, and child in the country -- and that's nearly double the per capita spend of other developed nations. Even with the premium price tag, our health outcomes are still lagging many of those other countries. However, there is still cause for optimism. We've diagnoses several of our health care's symptoms, and higher-level changes are taking place to provide some much-needed improvements. And while we're all very excited about improving our country's overall health, is there also a way to benefit from massive overhaul as investors? To help us answer that question, we've looked to our own team for guidance! 7investing lead advisor Dana Abramovitz has dedicated her career to improving health care in America. From an undergrad in pharmacy to a PhD in biochemistry to an industry consultant who advised CEOs, she's seen the industry from all angles and understands its biggest pain points. In her conversation with 7investing founder and CEO Simon Erickson, Dana describes why value-based care, personalized medicines, and a transition in thinking about "patients" as "consumers" will all be vitally important in the upcoming changes to health care. The two allude several times to Dana's new 7investing special report entitled "Can Technology Fix American Health Care", which is now freely available by clicking on this link. Publicly-traded companies mentioned in this interview include Alphabet (Nasdaq: GOOGL) and Apple (Nasdaq: AAPL). 7investing's advisors or its guests may have positions in the companies mentioned.

The pandemic has shown that America has a lot of problems with its healthcare system. There’s a political component to that, but there’s also a lot of private efforts underway to disrupt the current system. Maxx Chatsko and Dana Abramowitz join Dan Kline for 7investing Now to look at what’s happening in this space and what it means for investors. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

In this conversation, 7investing Lead Advisor Matthew Cochrane sits down with Ryan Krueger, the co-founder and CEO of Freedom Day Solutions, a family-owned and operated financial advisory firm located in Houston. Krueger believes that there are countless and confusing ways to plan for retirement. Even at their best, a withdrawal rate based on a projected return is a guess, sometimes based on just a little more than hopes and prayers.   Krueger thinks there's a better way to plan for retirement, built around a portfolio of assets that pay income to the investor. Investors then realize their “Freedom Day” is when the cash flow coming in exceeds their costs (needs and wants) going out. To help investors reach this goal, Krueger has launched the Freedom Day Dividend ETF (NYSE:MBOX). The MBOX ticker is a tip of the hat to dividend checks that used to hit investors' mailboxes at regular intervals when invested in quality companies that paid dividends.   The Freedom Day ETF is designed, as Krueger explains, to give investors growth of income, not growth or income. Krueger believes the ETF can accumulate a stable of quality companies that pay a rising dividend while avoiding many of the common pitfalls often associated with income investing, namely:    Not investing in companies with the highest yields;  Avoiding companies that nominally raise their dividends every year to please income investors;  Not investing in companies with unsustainable payout ratios.   Along the way, Cochrane and Krueger discuss several of MBOX's holdings, including EOG Resources (NYSE:EOG), Domino's Pizza (NYSE:DPZ), Broadcom (NASDAQ:AVGO), and Tractor Supply Co (NASDAQ:TSCO).   Krueger can be found on Twitter @RyanKruegerROI and you can find more information on his advisory firm (and excellent blog) at freedomdaysolutions.com. For more information on the Freedom Day Dividend ETF, you can visit freedomdaydividend.com.

Bipartisan legislation has been proposed in the House of Representatives that would impose significant regulation on large technology companies. The multiple bills, if passed, would change the rules for companies including Alphabet, Facebook, and Apple. This could result in some of these companies being broken up or having to sell some parts of their businesses. Steve Symington joins Dan Kline on “7investing Now” to break down what this means for investors. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

The advertising industry is continuously evolving. From billboards to newspapers, from radios to television, and from desktops to Smartphones, technology has been changing the way that companies appeal to prospective consumers for decades. And efficiency has always been at the very heart of advertising. Businesses are looking to grow their top line at the most optimal return on investment possible. The internet introduced new ways for companies to maximize that ROI of their ad spend. Search engines like Google (Nasdaq: GOOGL) and social networks like Facebook (Nasdaq: FB) have become massive platforms with billions of users. Together, they accounted for nearly 70% of the $370 billion the world spent on digital advertising last year. But these walled gardens have their limitations, and there's a fast-growing ad tech industry that is leveraging technology to provide new ways to connect advertisers with content publishers. It's growing quickly, yet it is still highly fragmented and is undergoing a wave of consolidation. How should growth-style investors, intrigued by the rapid pace of innovation in this gargantuan market, get exposure to the changes taking shape in this digital advertising space? To help us answer that question, 7investing founder and CEO Simon Erickson recently spoke with PubMatic co-founder and CEO Rajeev Goel. PubMatic is a publicly-traded company based in San Francisco, whose mission is to fuel the potential of internet content creators. It trades with the ticker "PUBM." In this exclusive interview with 7investing, Rajeev describes two of the most important innovations that have taken place in digital advertising during the past 15 years. The first was real-time bidding, which transformed the ad industry's transactions from static interactions to instantaneous online auctions. The second was a transition from desktop to mobile, which brought ads into apps and required them to be placed in different ways. But importantly, Rajeev also believes there is a third important innovation taking shape in the digital ad industry today: the intense focus on consumer privacy. Several companies are transitioning away from third-party cookies, and consumers are demanding for prompts to opt-in before their data is tracked or shared. Rajeev believes this trend could unlock a new wave of opportunities. Content publishers are increasingly looking to programmatic as a convenient and highly profitable way to generate revenue. As one of the clear innovators in the ad tech space, PubMatic is developing creative strategies to gain market share and to differentiate itself from competitors. This interview is a must-watch for any forward-thinking investors interested in the future of advertising! Publicly-traded companies mentioned in this interview include Adobe (Nasdaq: ADBE), Alphabet (Nasdaq: GOOGL), Apple (Nasdaq: AAPL), eBay (Nasdaq: EBAY), IPG (NYSE: IPG), NewsCorp (Nasdaq: NWS), Proctor and Gamble, PubMatic, The Trade Desk (Nasdaq: TTD), Zynga. 7investing's advisors or its guests may have positions in the companies mentioned.

Every 7investing lead advisor has a different method for evaluating companies. Some use a more technical style while others have a mixed approach that also involves personal experience. We all value different metrics in different ways and on this episode of “7investing Now,” Dan Kline and Maxx Chatsko will share how they pick the companies they invest in personally and how they find their monthly pick for 7investing members. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

The pandemic has changed some Americans’ minds about where they want to live. That has sent more people from big cities to smaller towns. Will this mean a resurgence for small-town Americans -- and what might that mean for investors. Dan Kine and Matt Cochrane will cover what’s happening and give you three companies poised to benefit from this population shift. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

Anirban Mahanti sat down with Mayur Thaker, a Senior Relationship Manager at Zacks Investment Research, to chat about hypergrowth investing. This conversation is all about investing in rapidly growing companies with huge addressable markets. As investors, we need a framework to study these options: how do we evaluate the investment opportunities in businesses at the bleeding edge of their respective domains? So, grab a coffee (or any other favorite drink!), and let's learn about hypergrowth investing. In this wide-ranging conversation, Mayur describes his investment journey. He started out when he was only 13-years old, investing a portion of his dad's portfolio. He won the lottery with the dot-com boom and then saw it all crumble.  And as a young adult working at Zacks, he experienced how the GFC was unraveling the very industry he was working in. We hear how his experience made him the investor he is today. A significant portion of the conversation is devoted to Tesla (Nasdaq: TSLA), where Mayur addresses the following topics: What is the high-level investment case for Tesla? Why should investors care? There are many bear cases for Tesla, including the historically low-margin and capital-intensive nature of manufacturing, reliance on regulatory credits, and impending competition. Mayur explains why many of these issues are irrelevant to the Tesla investment case as things stand today. What metrics should investors focus on when evaluating Tesla and why? What is the future of Tesla's energy business? What is a reasonable estimate of Tesla's fair value? And for those who want to explore beyond Tesla, we have you covered. Mayur outlines his thesis for two potential multibaggers -- Square (NYSE:SQ) and Beyond Meat (Nasdaq: BYND). Finally, we close, by putting it all together. Specifically, Mayur lays out his hypergrowth investment framework. I (Anirban here) identify closely with his methodology. I think it works well for patient, long-term focussed investors. Don’t miss this masterclass in hypergrowth investing. Trust me, this marathon conversation is well worth your time!

Our very first 7investing principle is that investing is personal. We believe no one knows your investing style, risk tolerance, or future goals better than you do. As such, the "right" way to invest and the "best" stocks in the market will necessarily be different for each individual.   But many people still feel like they don't understand the stock market or that investing is a game that's rigged against them. And while financial literacy is certainly improving every year, there's still a lot of work to be done.   7investing founder and CEO Simon Erickson recently reached out to two ambitious leaders who share the same mission of empowering others to become better investors. Kelsey Willock is the author of Not Your Boyfriend's Investment Advice, which encourages women to be more actively involved in financial decisions. Alan Soclof is the founder and CEO of Cruising Altitude, which aims to empower the Generation Z demographic to invest with a long-term horizon.   In this exclusive interview with 7investing, Kelsey and Alan chat with Simon about what prompted them to become entrepreneurs to improve the world's financial literacy and investing acumen. Kelsey describes how women are different investors than men and shares her thoughts about inflation and cryptocurrencies, while Alan describes the mentality of younger investors and draws comparisons between investing and sports.   In the final segment, both Kelsey and Alan share their personal investing approach and advice for younger investors.   Publicly-traded companies mentioned in this interview include Callaway Golf (NYSE: ELY) and Viacom (Nasdaq: VIAC). 7investing's advisors or its guests may have positions in the companies mentioned.

Internet security has gotten a lot more scrutiny after the Colonial Pipeline attack caused gas supply disruptions in parts of the United States. That’s only one of a few recent attacks which has caused more companies to to turn to Zscaler as well as other internet security solutions for help. Anirban Mahanti joins Dan Kline to break down Zscaler’s results and to discuss the rest of the internet security industry. He also takes a deep look at Ford’s electric vehicle plans and casts some doubt on the company’s long-term survival. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

Barry Kirk helps companies build customer loyalty programs,. In his position as a principal at Chapman & Co. he helps businesses deliver growth by showing them how to build a strong customer connection. He’s a strong advocate of the idea that “consumers are human beings first,” and that idea helps him work with companies to deliver “customer experiences that leverage behavior science, behavioral data analysis, persuasive design, and gamification,” according to his company bio. Kirk works with not just company leadership, but also employees, and customers. His efforts focus not just on building relationships with existing customers but also on building bonds with high potential customers -- people who should be loyal customers who are too focused on competitors. In a freewheeling discussion that looks at what many companies are wrong when it comes to how they treat consumers, Kirk sat down 7investing Lead Advisor Dan Kline. Kirk breaks down what drives customer loyalty and why so many companies get it wrong. He also explains how building a strong customer loyalty program can disrupt industries and details why it’s so hard for many businesses to fix their customer service problems. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

Robinhood has been all over the news as a stock platform used largely by younger traders -- people new to the market who maybe don’t really understand what they’re doing. It’s a platform that does bring buying stocks to a new audience but it’s also one that encourages inexperienced investors to do things that could be dangerous like buying on margin and using options. We’ll also kick the show off with a special announcement from 7investing CEO Simon Erickson. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

The stock market doesn’t have to be hard but it’s easy to make mistakes. People listen to the wrong advice, believe in things that just aren’t true, or fall into all sorts of traps. Steve Symington joins Dan Kline on 7investing Now to help you avoid some of the worst investing mistakes that are made every day. In addition, we’ll look at the big Virgin Galactic news and talk with David VanAmbrug about the state of the travel industry. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

It was a really busy week and the market was more volatile than usual. We’ll have much of the 7investing team on talking about what we make of the rough market for most of the week, the crypto crash, AT&T’s spinoff of WarnerMedia to combine it with Discovery, Target’s big earnings number, and much more. We’re also taking your questions and answering them live. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

In a decade since Marc Andreessen’s famous Wall Street Journal op-ed “Software is eating the world,” much has indeed transpired. The broad shift in technology and our economy towards software has taken place. Today, software is a critical component of almost every business, almost to the point where we can think of every business as a software business! Enterprise software, and in particular software as a service (SaaS), has become a key peg in this digital transformation journey. There are many established large enterprise software companies. Hundreds more are perhaps founded each year. What drives this interest in enterprise software? What’s the state of the union when it comes to SaaS technologies and their adoption? How are established companies and upstarts coexisting in this highly dynamic area? What is at the absolute forefront of enterprise software? To help us answer these questions, we sat down with Frank Wang, Engineering Director at Salesforce (NYSE: CRM) Frank is an entrepreneur with hands-on experience creating software solutions, growing engineering teams, and developing go-to-market strategies. He’s seen the evolution of SaaS up close for more than a decade, between his time at startups and software behemoths. In this interview with 7investing, Frank gives us his impression of where SaaS is in the adoption curve and delves into the pace of innovation at smaller companies versus established corporations. We discuss what areas are at the forefront of software right now and discuss some areas Frank finds exciting outside of software. We finish up with a discussion of 3 stocks Frank likes right now and why. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

Telemedicine has exploded during the pandemic. That makes sense since it was risky to go to a doctor’s office and that’s not something people ever enjoyed doing. What will telemedicine look like in the years to come? Dana Abramovitz joins Dan Kline to share her thoughts. Then, Anirban Mahanti joins us to break down what’s happening in the software as a service (SAAS) space. These companies have been struggling but that does not mean that many of these aren’t good long-term investments. Companies Mentioned  Teladoc (NYSE:TDOC)  CVS (NYSE:CVS)  Target (NYSE:TGT)  Cigna (NYSE:CI)  Slack (NYSE:WORK)  Salesforce (NYSE:CRM)  Disney (NYSE:DIS)  Verizon (NYSE:VZ) Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

This month, our 7investing team set our sights overseas.   China and Southeast Asia are lands of opportunity for investors. But what should we know about the region's consumers, regulations, and general business culture. And how is that different than other parts of the world?   To help us answer these questions, we've brought in an investing expert with a first-hand look at this region.  Chin Hui Leong is the Head of Investing at Singapore-based The Smart Investor (and also a former teammate of both Simon and Anirban). The Smart Investor provides stock commentary and market coverage for Singapore and several other parts of the world.  Chin has a direct perspective into Southeast Asian businesses and how they differ from other parts of the world.  In this exclusive interview with 7investing, Chin speaks with 7investing lead advisors Simon Erickson and Anirban Mahanti about the Southeast Asian consumer and how he/she is embracing e-commerce and adopting digital payments. The three also discuss the relationship between tech companies and the Chinese government and the mentality of Southeast Asian business leaders.    Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

The market has been volatile pretty much throughout the entire pandemic. As we start to put the past 15 or so months behind us, will that change? We’ll look at the path to recovery for growth stocks, whether the pandemic has created any permanent behavioral changes, and we’ll discuss what conventional wisdom is getting wrong. Companies Mentioned Fastly (NYSE:FSLY) Twilio (NYSE:TWLO) AT&T (NYSE:T) Palantir Technologies (NYSE:PLTR) C3.AI (NYSE:AI) Discovery Communications (NASDAQ:DISCA) Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

There's a lot of technology buzzwords flying around in the financial media these days. "Digital transformation", "cloud computing", "edge computing", and "artificial intelligence" are making their way into plenty of headlines and also into the conversations of more and more cocktail parties. The world is gaining a better understanding of what several cutting-edge trends actually mean.   But even more important than understanding them is following how these disruptive new technologies are actually being implemented. Businesses of all sizes are moving their workflows to the cloud service providers like Amazon (Nasdaq: AMZN) Web Services and Google (Nasdaq: GOOGL) Cloud Platform. They're hiring data scientists to set up machine learning environments, and they're assembling teams of hundreds or thousands of engineers to undertake massive new projects. There are a lot of dollars at stake as the digital transformation more firmly takes root within the enterprise.   What will all of this mean for investors? Are there ways to capitalize on the biggest trends taking shape in the tech world? To help us answer these questions, we've brought in an expert who is at the forefront of innovation. Ben Book is the co-founder and CEO of GigaOm, who is helping IT decision makers tackle their most complex technical challenges. GigaOm is bringing the executives of progressive companies up-to-speed about emerging technologies and then helping to implement them across their organizations. In this exclusive interview with 7investing, Ben digs deep into what's really going on in today's biggest trends. He explains what the digital transformation is really all about and why we're still just "in the second or third inning." He describes how cloud computing is allowing companies to simplify their IT operations and how machine learning is now being used for more customized applications. Previously a healthcare consultant, Ben also sheds some insight on where tech companies have the greatest chances of succeeding in health care.   Finally, Simon asks Ben to share several other trends he's excited about right now.   Publicly-traded companies mentioned in this interview include Alphabet (Nasdaq: GOOGL), Amazon (Nasdaq: AMZN), Datadog (Nasdaq: DDOG), Disney (NYSE: DIS), Microsoft (Nasdaq: MSFT), and Snowflake (Nasdaq: SNOW), and Zoom Video Communications (Nasdaq: ZM). 7investing's advisors or its guests may have positions in the companies mentioned.

The market has not been kind to most tech stocks over the past few weeks. That’s hard to watch in the short-term, but our long-term convictions have not changed. Good companies can have major negative moves in their share price in the short-term while still being huge winners in the long-term. Simon Erickson and Maxx Chatsko join Dan Kline to talk about market volatility, sector rotation, and why we consider this a buying opportunity on Wednesday’s 7investing Now. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

In this conversation, 7investing Lead Advisor Matthew Cochrane sits down with Marcelo Lima, the founder and managing partner of Heller House. On the Heller House's website, it states, "As acolytes of Benjamin Graham and Warren Buffett, we are standing on the shoulders of giants and adapting to a world permeated by software, network effects and zero marginal costs." Lima describes his evolution from a Warren Buffett-type value investor to an investor who instead seeks out the world's most innovative companies. He even wonders if starting as a Buffett investor hindered him early on in his investment career because he believed Buffett that new technology was too hard to understand. When studying new technologies, Lima says he approaches everything like he's a student. That can mean purchasing 900-page textbooks on the microbiology of cells or attending developer conferences and trying out new software products.  A few years ago, when studying Amazon.com (NASDAQ:AMZN) he toured one of its fulfillment centers. This experience helped him appreciate how advances in robotics would help the e-commerce giant become even more efficient at delivery and logistics. Lima also discusses the size and valuations of tech giants. He believes the total addressable markets more than justifies some of today's larger market caps but believes valuation must always be carefully weighed with a company's optionality and growth. Along the way, Lima and Cochrane also discuss the possibility of Miami as the next great tech hub, why Mark Zuckerberg is perennially underrated, and whether virtual and augmented reality is an inevitable platform.

Walmart has agreed to acquire telemedicine provider MeMD which will expand the company’s healthcare efforts beyond its own employees. It’s pretty clear that Americans want something different in healthcare but it’s a very crowded space and the current healthcare system has some massive advantages. Walmart does, however, have over 4,000 pharmacies and buying an established player in the telemedicine space could accelerate its efforts. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

It was a rough day for a number of tech stocks yesterday. There were double-digit drops and as investors, it’s easy to get spooked by that. We’ll look at the difference between volatility and risk as well as why big drops are sometimes a feature and not a bug on the Friday edition of 7investing Now. We know it’s scary and the 7investing team is here for you! Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

It has been a busy few days for the United States as the pandemic-related news has been fast and furious. Pfizer reported better-than-expected profits and a lot of its revenue has come from the COVID-19 vaccine. Maxx Chatsko joins Dan Kline to talk about that, President Joe Biden’s plan to have 70% of American adults get at least one vaccine shot by July, the changing landscape for retail and restaurants, and T-Mobile earnings. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing